Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated

被引:18
作者
Guo, XC [1 ]
Schrader, KA [1 ]
Xu, YX [1 ]
Schrader, JW [1 ]
机构
[1] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
M-Ras; leukemia; mastocytosis; H-Ras dendritic cell;
D O I
10.1038/sj.onc.1208441
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of constitutively activated M-Ras in normal murine bone-marrow cells was sufficient to induce the factor-independent, in vitro growth and differentiation of colonies of macrophages and neutrophils, and the generation of immortal lines of factor-independent mast cells, and, upon in vivo injection of the transduced cells, a fatal mastocytosis/mast-cell leukemia. In contrast, expression of constitutively activated H-Ras in bone-marrow cells resulted in the in vitro growth, in the absence of exogenous factors, of colonies that contained only macrophages and of lines of cells resembling dendritic cells, and, upon in vivo injection of the transduced cells, a fatal histiocytosis/monocytic leukemia. Macrophages generated by bone-marrow cells expressing activated M-Ras or activated H-Ras differed morphologically, the latter appearing more activated, a difference abrogated by an inhibitor of Erk activation. Inhibition of either Erk or PI3 kinase blocked the capacity of both activated M-Ras and activated H-Ras to support proliferation and viability. However, inhibition of p38 MAPK activity suppressed proliferation of bone-marrow cells expressing activated H-Ras, but enhanced that of bone-marrow cells expressing activated M-Ras. Thus, expression of either activated M-Ras or H-Ras in normal hematopoietic cells was sufficient for transformation but each resulted in the generation of distinct lineages of cells.
引用
收藏
页码:2330 / 2342
页数:13
相关论文
共 80 条
[1]   REVERSIBLE ABROGATION OF IL-3 DEPENDENCE BY AN INDUCIBLE H-RAS ONCOGENE [J].
ANDREJAUSKAS, E ;
MORONI, C .
EMBO JOURNAL, 1989, 8 (09) :2575-2581
[2]  
BASHEY A, 1992, BLOOD, V79, P981
[3]  
BOS JL, 1989, CANCER RES, V49, P4682
[4]   Increasing complexity of Ras signaling [J].
Campbell, SL ;
Khosravi-Far, R ;
Rossman, KL ;
Clark, GJ ;
Der, CJ .
ONCOGENE, 1998, 17 (11) :1395-1413
[5]   Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway [J].
Chen, CY ;
Del Gatto-Konczak, F ;
Wu, ZG ;
Karin, M .
SCIENCE, 1998, 280 (5371) :1945-1949
[6]   The p38 pathway provides negative feedback for Ras proliferative signaling [J].
Chen, G ;
Hitomi, M ;
Han, JH ;
Stacey, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :38973-38980
[7]   ACTIVATION OF MAP KINASE KINASE IS NECESSARY AND SUFFICIENT FOR PC12 DIFFERENTIATION AND FOR TRANSFORMATION OF NIH 3T3 CELLS [J].
COWLEY, S ;
PATERSON, H ;
KEMP, P ;
MARSHALL, CJ .
CELL, 1994, 77 (06) :841-852
[8]   Direct interaction of jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation [J].
Danial, NN ;
Losman, JA ;
Lu, TH ;
Yip, N ;
Krishnan, K ;
Krolewski, J ;
Goff, SP ;
Wang, JYJ ;
Rothman, PB .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (11) :6795-6804
[9]   Protein kinase C mediates mutant N-Ras-induced developmental abnormalities in normal human erythroid cells [J].
Darley, RL ;
Pearn, L ;
Omidvar, N ;
Sweeney, M ;
Fisher, J ;
Phillips, S ;
Hoy, T ;
Burnett, AK .
BLOOD, 2002, 100 (12) :4185-4192
[10]   Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursors [J].
Darley, RL ;
Burnett, AK .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (11) :1599-1608